Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Many budgets falter due to vague goals, rigidity, or inconsistent tracking. Here’s why Why Most Budgets Do Not Work and how to fix it.
27,292 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Summit Sotheby’s International Realty dominates Utah’s 2026 RealTrends Verified rankings, placing the most agents in ...
The FCC's proposed rules to curb illegal robocalls could unintentionally broaden the data telecoms hold on users, boo...
A new analysis shows Microsoft’s AI-driven revenue pace hitting fresh highs, suggesting meaningful upside for patient...
Micron’s stock sprinted higher on AI-driven demand, prompting a strategist to flag a potential entry on a pullback. T...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
Charter Communications is weighing a potential partnership with SpaceX’s Starlink as it eyes wireless expansion. The ...
May 2026 delivered a dramatic uptick in tokenized pre-IPO trading, led by SpaceX as the Nasdaq listing approached, wi...
The Dow finished the first half of the year on a high note, marking its strongest run since 2021. Yet a softer jobs r...
SK Hynix plans a $29 billion U.S. listing to capitalize on AI memory chip demand, highlighting a push to broaden inve...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
FuelCell Energy priced a $225 million stock offering at $21 per share, triggering a 14% slide and dragging peers Bloo...